Mycophenolate versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

OBJECTIVE: To compare mycophenolate (MMF) with placebo for the treatment of systemic sclerosis-related interstitial lung disease (SSc-ILD). METHODS: Participants enrolled in the placebo arm of Scleroderma Lung Study (SLS) I and the MMF arm of SLS II were included. SLS I randomized participants to or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Rheumatol
Main Authors: Volkmann, Elizabeth R., Tashkin, Donald P., Li, Ning, Roth, Michael D., Khanna, Dinesh, Hoffmann-Vold, Anna-Maria, Kim, Grace, Goldin, Jonathan, Clements, Philip J., Furst, Daniel E., Elashoff, Robert M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5560126/
https://ncbi.nlm.nih.gov/pubmed/28376288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados